1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Viral Vaccines Market, By Type
5.1 Introduction
5.2 Monovalent Vaccines
5.3 Multivalent Vaccines
6 Global Viral Vaccines Market, By Form
6.1 Introduction
6.2 Liquid
6.3 Lyophilized
7 Global Viral Vaccines Market, By Container Format
7.1 Introduction
7.2 Vials
7.3 Prefilled Syringes
8 Global Viral Vaccines Market, By Biosafety Level Type
8.1 Introduction
8.2 Biosafety Level 1
8.3 Biosafety Level 2
8.4 Biosafety Level 3
8.5 Biosafety Level 4
9 Global Viral Vaccines Market, By Technology
9.1 Introduction
9.2 Excluding COVID 19 Vaccines
9.2.1 Conjugate Vaccines
9.2.2 Inactivated & Subunit Vaccines
9.2.3 Live Attenuated Vaccines
9.2.4 Recombinant Vaccines
9.2.5 Toxoid Vaccines
9.2.6 Viral vector Vaccines
9.3 Including COVID 19 Vaccine
9.3.1 Messenger Ribonucleic Acid (mRNA) Vaccines
9.3.2 Viral Vector Vaccines
9.4 Other Technologies
10 Global Viral Vaccines Market, By Disease
10.1 Introduction
10.2 Influenza
10.3 Pneumococcal Diseases
10.4 Combination Vaccines
10.5 Human Papillomavirus (HPV)
10.6 Herpes Zoster
10.7 Meningococcal Diseases
10.8 Rotavirus
10.9 Measles, Mumps, Rubella (MMR)
10.10 Varicella
10.11 Hepatitis
10.12 Diphtheria, Tetanus and Pertussis (DTP)
10.13 Polio
10.14 COVID 19
10.15 Other Diseases
11 Global Viral Vaccines Market, By Age of Administration
11.1 Introduction
11.2 Pediatric Vaccine
11.3 Adult Vaccine
12 Global Viral Vaccines Market, By Route of Administration
12.1 Introduction
12.2 Intramuscular & Subcutaneous Administration
12.3 Oral Administration
12.4 Other Routes Of Administrations
13 Global Viral Vaccines Market, By End User
13.1 Introduction
13.2 Community Hospitals
13.3 Hospitals
13.4 Specialty Centres
13.5 Clinics
13.6 Other End Users
14 Global Viral Vaccines Market, By Geography
14.1 Introduction
14.2 North America
14.2.1 US
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 Germany
14.3.2 UK
14.3.3 Italy
14.3.4 France
14.3.5 Spain
14.3.6 Rest of Europe
14.4 Asia Pacific
14.4.1 Japan
14.4.2 China
14.4.3 India
14.4.4 Australia
14.4.5 New Zealand
14.4.6 South Korea
14.4.7 Rest of Asia Pacific
14.5 South America
14.5.1 Argentina
14.5.2 Brazil
14.5.3 Chile
14.5.4 Rest of South America
14.6 Middle East & Africa
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Qatar
14.6.4 South Africa
14.6.5 Rest of Middle East & Africa
15 Key Developments
15.1 Agreements, Partnerships, Collaborations and Joint Ventures
15.2 Acquisitions & Mergers
15.3 New Product Launch
15.4 Expansions
15.5 Other Key Strategies
16 Company Profiling
16.1 AstraZeneca plc
16.2 Emergent BioSolutions Inc.
16.3 GlaxoSmithKline plc
16.4 Merck & Co., Inc.
16.5 Moderna, Inc.
16.6 Novartis, Inc.
16.7 Novavax, Inc.
16.8 Pfizer, Inc.
16.9 Sanofi
16.10 Seqirus (CSL Limited)
16.11 Serum institute of India Private Limited
List of Tables
Table 1 Global Viral Vaccines Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Viral Vaccines Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Viral Vaccines Market Outlook, By Monovalent Vaccines (2021-2030) ($MN)
Table 4 Global Viral Vaccines Market Outlook, By Multivalent Vaccines (2021-2030) ($MN)
Table 5 Global Viral Vaccines Market Outlook, By Form (2021-2030) ($MN)
Table 6 Global Viral Vaccines Market Outlook, By Liquid (2021-2030) ($MN)
Table 7 Global Viral Vaccines Market Outlook, By Lyophilized (2021-2030) ($MN)
Table 8 Global Viral Vaccines Market Outlook, By Container Format (2021-2030) ($MN)
Table 9 Global Viral Vaccines Market Outlook, By Vials (2021-2030) ($MN)
Table 10 Global Viral Vaccines Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 11 Global Viral Vaccines Market Outlook, By Biosafety Level Type (2021-2030) ($MN)
Table 12 Global Viral Vaccines Market Outlook, By Biosafety Level 1 (2021-2030) ($MN)
Table 13 Global Viral Vaccines Market Outlook, By Biosafety Level 2 (2021-2030) ($MN)
Table 14 Global Viral Vaccines Market Outlook, By Biosafety Level 3 (2021-2030) ($MN)
Table 15 Global Viral Vaccines Market Outlook, By Biosafety Level 4 (2021-2030) ($MN)
Table 16 Global Viral Vaccines Market Outlook, By Technology (2021-2030) ($MN)
Table 17 Global Viral Vaccines Market Outlook, By Excluding COVID 19 Vaccines (2021-2030) ($MN)
Table 18 Global Viral Vaccines Market Outlook, By Conjugate Vaccines (2021-2030) ($MN)
Table 19 Global Viral Vaccines Market Outlook, By Inactivated & Subunit Vaccines (2021-2030) ($MN)
Table 20 Global Viral Vaccines Market Outlook, By Live Attenuated Vaccines (2021-2030) ($MN)
Table 21 Global Viral Vaccines Market Outlook, By Recombinant Vaccines (2021-2030) ($MN)
Table 22 Global Viral Vaccines Market Outlook, By Toxoid Vaccines (2021-2030) ($MN)
Table 23 Global Viral Vaccines Market Outlook, By Viral vector Vaccines (2021-2030) ($MN)
Table 24 Global Viral Vaccines Market Outlook, By Including COVID 19 Vaccine (2021-2030) ($MN)
Table 25 Global Viral Vaccines Market Outlook, By Messenger Ribonucleic Acid (mRNA) Vaccines (2021-2030) ($MN)
Table 26 Global Viral Vaccines Market Outlook, By Viral Vector Vaccines (2021-2030) ($MN)
Table 27 Global Viral Vaccines Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 28 Global Viral Vaccines Market Outlook, By Disease (2021-2030) ($MN)
Table 29 Global Viral Vaccines Market Outlook, By Influenza (2021-2030) ($MN)
Table 30 Global Viral Vaccines Market Outlook, By Pneumococcal Diseases (2021-2030) ($MN)
Table 31 Global Viral Vaccines Market Outlook, By Combination Vaccines (2021-2030) ($MN)
Table 32 Global Viral Vaccines Market Outlook, By Human Papillomavirus (HPV) (2021-2030) ($MN)
Table 33 Global Viral Vaccines Market Outlook, By Herpes Zoster (2021-2030) ($MN)
Table 34 Global Viral Vaccines Market Outlook, By Meningococcal Diseases (2021-2030) ($MN)
Table 35 Global Viral Vaccines Market Outlook, By Rotavirus (2021-2030) ($MN)
Table 36 Global Viral Vaccines Market Outlook, By Measles, Mumps, Rubella (MMR) (2021-2030) ($MN)
Table 37 Global Viral Vaccines Market Outlook, By Varicella (2021-2030) ($MN)
Table 38 Global Viral Vaccines Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 39 Global Viral Vaccines Market Outlook, By Diphtheria, Tetanus and Pertussis (DTP) (2021-2030) ($MN)
Table 40 Global Viral Vaccines Market Outlook, By Polio (2021-2030) ($MN)
Table 41 Global Viral Vaccines Market Outlook, By COVID 19 (2021-2030) ($MN)
Table 42 Global Viral Vaccines Market Outlook, By Other Diseases (2021-2030) ($MN)
Table 43 Global Viral Vaccines Market Outlook, By Age of Administration (2021-2030) ($MN)
Table 44 Global Viral Vaccines Market Outlook, By Pediatric Vaccine (2021-2030) ($MN)
Table 45 Global Viral Vaccines Market Outlook, By Adult Vaccine (2021-2030) ($MN)
Table 46 Global Viral Vaccines Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 47 Global Viral Vaccines Market Outlook, By Intramuscular & Subcutaneous Administration (2021-2030) ($MN)
Table 48 Global Viral Vaccines Market Outlook, By Oral Administration (2021-2030) ($MN)
Table 49 Global Viral Vaccines Market Outlook, By Other Routes Of Administrations (2021-2030) ($MN)
Table 50 Global Viral Vaccines Market Outlook, By End User (2021-2030) ($MN)
Table 51 Global Viral Vaccines Market Outlook, By Community Hospitals (2021-2030) ($MN)
Table 52 Global Viral Vaccines Market Outlook, By Hospitals (2021-2030) ($MN)
Table 53 Global Viral Vaccines Market Outlook, By Specialty Centres (2021-2030) ($MN)
Table 54 Global Viral Vaccines Market Outlook, By Clinics (2021-2030) ($MN)
Table 55 Global Viral Vaccines Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
